2 companies in Synthetic biology, publicly listed.
Twist Bioscience
Synthetic biology · DNA synthesis
Latest (Aug 4, 2026): Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock
Open profile →Ginkgo Bioworks
Synthetic biology · Cell programming and biosecurity
Latest (Aug 5, 2026): Ginkgo Bioworks Reports Second Quarter 2026 Results, Wins Government Contracts to Build Autonomous Labs at MIT, Caltech, Northwestern, and University of Maryland
Open profile →Coverage is not an offer to invest. Private ownership does not imply available shares. Sector labels are Sapien Frontier’s own coverage classification, not company claims.
Missing a company? Request future coverage. We add a company when its filings, offering notices or awards can be followed reliably. See what we cover and how often.